Purchases and Sales Made in Q2 2024 in Immunovant, Inc. (IMVT)
This table provides information about the institutional ownership of Immunovant, Inc. (IMVT) during Q2 2024. The information is specifically focused on institutions that hold shares of Immunovant, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-67.4K- 93.93% |
$1.69M - $2.13M
|
4.36K
$120K
|
|
|
Aug 13, 2024
Q2 2024
|
Castleark Management LLC
Chicago, IL |
SELL
|
- |
-75.3K- 93.55% |
$1.89M - $2.38M
|
5.19K
$143K
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-78.8K- 13.73% |
$1.98M - $2.49M
|
495K
$13.6M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-83.2K- 41.07% |
$2.09M - $2.63M
|
119K
$3.28M
|
|
|
Aug 14, 2024
Q2 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-86K- 75.82% |
$2.16M - $2.72M
|
27.4K
$755K
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-90.5K- 7.15% |
$2.27M - $2.86M
|
1.17M
$32.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-111K- 52.96% |
$2.78M - $3.5M
|
98.4K
$2.71M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-121K- 12.89% |
$3.04M - $3.82M
|
817K
$22.5M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-121K- 12.89% |
$3.04M - $3.82M
|
817K
$22.5M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-122K- 50.05% |
$3.06M - $3.85M
|
122K
$3.35M
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-149K- 51.38% |
$3.73M - $4.7M
|
141K
$3.87M
|
|
|
Aug 14, 2024
Q2 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-163K- 63.64% |
$4.08M - $5.14M
|
92.9K
$2.56M
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-184K- 40.01% |
$4.61M - $5.81M
|
275K
$7.57M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-218K- 87.35% |
$5.48M - $6.9M
|
31.6K
$869K
|
|
|
Aug 14, 2024
Q2 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-249K- 25.73% |
$6.26M - $7.88M
|
720K
$19.8M
|
|
|
Aug 13, 2024
Q2 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-371K- 90.94% |
$9.31M - $11.7M
|
36.9K
$1.02M
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-500K- 26.87% |
$12.6M - $15.8M
|
1.36M
$37.5M
|
|
|
Aug 14, 2024
Q2 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-664K- 52.21% |
$16.7M - $21M
|
608K
$16.7M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-923K- 25.34% |
$23.2M - $29.2M
|
2.72M
$74.8M
|
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.04M- 35.08% |
$26.1M - $32.9M
|
1.92M
$52.9M
|
|
|
Aug 14, 2024
Q2 2024
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-1.2M- 67.61% |
$30.1M - $37.9M
|
575K
$15.8M
|